🔗 Share this article

This year's Nobel Prize in medical science has been granted for revolutionary discoveries that clarify how the body's defense network targets dangerous pathogens while protecting the healthy tissues.

Three esteemed researchers—from Japan Prof. Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—share this honor.

The work uncovered unique "sentinels" within the immune system that eliminate malfunctioning defense cells that could harming the body.

These findings are now paving the way for new therapies for immune disorders and cancer.

These winners will divide a monetary award valued at 11 million Swedish kronor.

Crucial Findings

"Their work has been decisive for comprehending how the immune system functions and the reason we don't all suffer from severe self-attack conditions," stated the head of the Nobel Committee.

The trio's studies explain a core question: In what way does the defense system defend us from countless invaders while leaving our healthy cells unharmed?

Our body's protection system uses immune cells that scan for indicators of disease, including pathogens and bacteria it has never encountered.

These defenders employ sensors—called recognition units—that are produced by chance in a vast number of variations.

That provides the defense network the capacity to fight a broad range of invaders, but the unpredictability of the process inevitably creates immune cells that can target the host.

Protectors of the Body

Scientists previously knew that some of these problematic white blood cells were destroyed in the immune organ—the site where white blood cells mature.

This year's Nobel Prize honors the discovery of T-reg cells—described as the immune system's "security guards"—which patrol the body to neutralize any immune cells that attack the healthy cells.

We know that this process fails in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.

A Nobel panel added, "These discoveries have established a novel area of investigation and spurred the creation of new treatments, for instance for cancer and autoimmune diseases."

In malignancies, T-regs prevent the system from fighting the growth, so studies are aimed at reducing their numbers.

In self-attack disorders, trials are testing increasing regulatory T-cells so the organism is not being harmed. A comparable approach could also be useful in minimizing the chances of organ transplant rejection.

Innovative Experiments

Prof Shimon Sakaguchi, of Osaka University, performed experiments on mice that had their immune gland extracted, causing self-attack conditions.

He showed that introducing immune cells from other animals could prevent the disease—implying there was a system for blocking immune cells from harming the host.

Mary Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an genetic immune disorder in mice and humans that resulted in the identification of a genetic factor critical for the way T-regs operate.

"The pioneering work has uncovered how the immune system is controlled by regulatory T cells, stopping it from mistakenly targeting the healthy cells," said a prominent physiology specialist.

"This research is a remarkable example of how fundamental biological study can have broad consequences for human health."